Introduction
A concern in the development of chemopreventive and therapeutic agents, including pharmaceuticals and dietary supplements, is the development of unexpected toxicity in various target tissues, such as liver or kidney, during clinical trials. Cancer preventive agents either are taken by the general public or are prescribed for high risk patients. In many cases, individuals, either patients or the general public, will use the agents for the remainder of their life. It is therefore critically important that chemopreventive agents not be toxic. While an agent may have strong chemopreventive efficacy or therapeutic index for breast cancer, it may have unacceptable cytotoxicity or induce aberrant function or growth in organ specific tissues. Such variability could limit the drug's use and perhaps prevent its incorporation into cancer prevention or therapy strategies. Variations in organ specific sensitivity could also explain the differences in response between different screening assays and the differing efficacy for different types of cancer. While some mechanisms of cytotoxicity are probably common for most tissues, target organ specific toxicities are thought to reflect the uniqueness of individual organ expression which results in differences in metabolic potential and receptor expression between different tissues. Although the in vitro assays were developed specifically to evaluate cancer chemopreventive agents, they can be used for screening almost any chemical agent that can be incorporated into culture media. Cytotoxicity includes changes in the normal cellular growth or expression which alters the ability of the cell to reproduce itself or maintain its normal tissue specific function. 22: 17-24 (2000 Abstract. The Human Epithelial Cell Cytotoxicity (HECC) Assay for determining organ specific cytotoxicity uses human epithelial cells from eight different human tissues, including: skin, mammary, prostate, renal, bronchial, oral, ecto-cervix, and liver. Although the initial studies using this assay were conducted using cancer chemopreventive agents, the HECC Assay can also be used to evaluate other types of drugs, personal care products, environmental chemicals, and potential toxicants. Human epithelial cells at an early passage are seeded into multi-well dishes. The cells are exposed to multiple concentrations of a test agent for a three day period. The concentration ranges for test agents in the assay are determined in a preliminary assay using an exposure The Range-Finding Assay determines the potential of each agent to inhibit growth (measured by methylene blue staining) after a five day exposure. The Human Epithelial Cell Cytotoxicity (HECC) Assay determines the potential of each agent to inhibit growth, mitochondrial function, and PCNA or albumin expression after a three day exposure. Each of these endpoints can provide a quantitative response assessment based on agent concentration. The data can be used to determine the TC 50 value for each agent with each target specific epithelial cell. We recognize that cytotoxicity studies with epithelial cell cultures has its limitations in that the complex interactions and metabolism found in vivo are not duplicated; however, data obtained using epithelial cells at early passage levels from different normal tissues should reflect some of the tissue differences. Cytotoxicity data obtained with cells from relevant normal human tissues can provide comparative target tissue sensitivity data and important information to support the selection of the initial clinical trial dose level. If available, data from clinical trials can be used to determine the relevance of any observed differences in cytotoxicity in the epithelial cells from the different tissues.
Methods in Cell Science
The target cells selected for this study were chosen based on the following criteria: 1) isolation from apparently normal tissue, 2) expression of biomarkers found in normal cells from the target tissue, 3) availability from a commercial or primary source, 4) growth properties that would facilitate their use in screening assays, 5) the absence of microbial or adventitious agent contamination, and most importantly 6) the relevance of the target tissue for human health, cancer, and/or sensitivity to toxic injury. The human epithelial cells used in this study were obtained by primary isolation from apparently normal tissues obtained from the UCI Medical Center or purchased from Biowhittaker (Clonetics), Walkersville, MD. The epithelial cells from the following human target tissues were used in this study. Human foreskin epidermal cells may be obtained from commercial sources; however, the cell lines used in our laboratory were established, using the method of Steele et al., 1998 [1] , from foreskin tissues, which were obtained from UCI's Medical Center. Human mammary epithelial cells exhibit excellent growth properties and express cytokeratin 14 and 18 but do not express cytokeratin 19. Human renal proximal tubule epithelial cells exhibit excellent growth properties and are positive for gamma GTP. Human bronchial epithelial cells and are positive for cytokeratin 19. Human prostate epithelial cells exhibit excellent growth properties are positive for cytokeratins 5, 6, and 18 (clone 8, 13). Human ecto-cervical epithelial cells are positive for cytokeratin 13. Human hepatocytes are provided as primary cultures from apparently normal tissue and have the capability for albumin synthesis. Human oral mucosal cells were established from tonsillectomy specimens using a method modified from that of Steele et al. [1] .
The endpoints chosen were selected based on their relevance to cytotoxicity in various target tissues, their reproducibility, and the ease of incorporation into multi-well culture plates to facilitate data collection and quantification. Each assay includes a positive control and the appropriate solvent (negative) control. We have previously reported that methylene blue can be used to quantify inhibition of cellular growth for epithelial cells [2] . Methylene blue staining was used with the range finding studies to provide the initial assessments of cytotoxicity and to guide the selection of concentrations for the Human Epithelial Cell Cytotoxicity Assay (HECC). In addition, it was used in the HECC Assay to assess cytotoxicity and to normalize for relative cell number for the Alamar blue, PCNA expression, and albumin synthesis (hepatocytes) endpoints.
Alamar blue was used to assess mitochondrial function. Alamar blue [3] is a specific redox stain which is converted from blue to red in the presence of cells with metabolically active mitochondria and is similar to MTT but without the precipitation that can be associated with MTT staining. Alamar blue can be added directly to the culture medium permitting the endpoint to be measured without removing the culture medium [3] . Another advantage is that Alamar blue is relatively non-toxic and thus the medium containing the reacted dye can be removed and the cells used to assess growth by methylene blue staining. Cytotoxicity that reduces mitochondrial synthesis or function will reduce the conversion of Alamar blue.
Following the assessment of the Alamar blue endpoint, the Alamar blue plates were used to determine the relative cell number per culture well using methylene blue. The values for mitochondrial function and PCNA or albumin expression were normalized using this data. The HECC Assay endpoints were assessed in parallel experiments and were used to determine the concentration that inhibited growth by fifty percent (TC 50 ) of each chemopreventive agent for each endpoint.
PCNA expression was used to assess changes in the growth status of the cultures. PCNA is expressed as cells enter the S-phase of the cell cycle and is the DNA polymerase delta auxiliary protein [4] [5] [6] [7] . The modulation of PCNA expression provides an important indicator of early changes in cellular growth that may be associated with agent exposure that may not be evident in the growth inhibition or viability endpoints.
Albumin synthesis was used to assess the status of hepatocyte cultures. Hepatocytes are known to have the ability to synthesize albumin. Inhibition of albumin synthesis is an indicator of a toxic response in these cells.
